Raolat Abdulai, MD, MS
CLINICAL DIRECTOR OF RESEARCH, SANOFI
Cambridge, Massachusetts, United States
Dr. Abdulai joined Sanofi in 2018 where she serves as a clinical research director for the Immunology and Inflammation (I&) division. In addition to her drug development work, she acts as a digital enabler and works to advance the Sanofi digital health strategy within I&I. This includes advancing technology in R&D that transforms the product life cycle for faster and more efficient clinical trials: integrating real world data to identify the right patient population, using analytics to drive new indications, and incorporating wearables and digital tools into clinical trials. Dr. Abdulai has a Master of Medical Science in Biomedical Informatics from Harvard Medical School. She attended medical school at Howard University College of Medicine, completed internal medicine training at the Mayo Clinic in Rochester, MN and Pulmonary and Critical Care fellowship at Brigham and Women's Hospital in Boston, MA. She is triple board certified and continues to practice by volunteering at a Boston-based community health center where she treats patients with asthma and chronic obstructive pulmonary disease. While in medical school, Dr. Abdulai co-founded the New Freedmen’s clinic to provide free holistic care to the uninsured and underinsured local population. In 2009, Dr. Abdulai was featured in O! Oprah Magazine as one of 80 inspirational women entrepreneurs from around the country for the O! Oprah Magazine-White House Project Leadership Conference. Among her many other honors, Dr. Abdulai was invited to the White House for President Obama’s Innovative Programs Summit which highlighted impactful social entrepreneurship programs across the country. Her passions including increasing access to clinical trials for women and people of color. Her personal project into this area was chosen for the Harvard iLab Venture Incubation Program in 2016.
While most of the attention in the use of digital health for chronic care management has gone to…